TRAX Activators
TRAX activators encompass a specialized category of chemicals that target and amplify the functional activity of the TRAX protein, a component crucial for cellular processes such as RNA interference and modulation of gene expression. These compounds operate through various biochemical pathways to enhance TRAX activity, ensuring that its role in the cellular machinery is carried out more effectively. One mechanism through which these activators function is by stabilizing the formation of the TRAX-Translin complex, which is pivotal for the processing of small RNAs, thereby facilitating a more efficient RNA interference pathway. Another subset of TRAX activators works by upregulating the activity of proteins that interact directly with TRAX. This interaction amplifies the signal required for TRAX to engage in its role within the RNA-induced silencing complex (RISC), thereby boosting gene silencing efficacy. These activators not only enhance the stability and function of TRAX but also promote its interaction with other key proteins involved in the RNA interference pathway.
Additionally, TRAX activators can influence post-translational modifications of the TRAX protein. By affecting the phosphorylation state of TRAX, these compounds can alter its activity state, promoting a more active form of the protein. Some activators achieve this by inhibiting phosphatases that dephosphorylate TRAX, thus maintaining TRAX in a phosphorylated and active state. Others might act by modulating the availability of co-factors required for the enzymatic activity that TRAX is part of, ensuring that the protein has all necessary components to function optimally. Through these intricate molecular interactions and modifications, TRAX activators ensure the robust performance of the protein's role in the RNA interference pathway, which is central to the regulation of gene expression and the maintenance of genomic stability. The comprehensive understanding of these activators and their mechanisms provides valuable insights into the modulation of TRAX activity at a molecular level.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP, which in turn activates PKA. PKA phosphorylation can enhance TRAX interaction with its partners in RNA-induced silencing complexes (RISC), thereby increasing its functional activity in RNA interference. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
A polyamine that can stabilize the formation of RNA-induced silencing complexes in which TRAX is a component, potentially enhancing its activity in RNA processing and modulation. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
NF-κB pathway inhibitor that can lead to the alteration of cellular stress responses, indirectly enhancing TRAX's role in stress granule dynamics and mRNA metabolism. | ||||||
K-252a | 99533-80-9 | sc-200517 sc-200517B sc-200517A | 100 µg 500 µg 1 mg | $129.00 $214.00 $498.00 | 19 | |
An inhibitor of protein kinase C (PKC), which can modulate the phosphorylation status of proteins interacting with TRAX, potentially augmenting its role in RNA interference pathways. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can enhance TRAX's stability by reducing its degradation, indirectly increasing the functional pool of TRAX in the cell. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor which can modify TRAX's participation in PI3K/Akt signaling pathways by affecting its associated protein-protein interactions. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor which can shift the balance of MAPK/ERK signaling, indirectly influencing TRAX's activity related to mRNA stabilization and degradation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor which can lead to chromatin remodeling, thus modulating gene expression and potentially upregulating TRAX's functional partners. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
An Aurora kinase inhibitor that can impact mitotic progression, influencing TRAX's role in cell cycle regulation through RNA silencing mechanisms. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
A cyclin-dependent kinase inhibitor that can alter cell cycle progression, potentially modulating TRAX's interactions with the machinery involved in mRNA turnover during the cell cycle. | ||||||